Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Preferred Stock ETFs Face New Test

Preferred stocks offer the distinction of being unique hybrid instruments with qualities of both stocks and bonds. In that manner, they offer healthy dividend yields alongside a favored position in the capital structure of many companies that issue these securities.

The reason companies issue preferred shares is to raise capital from investors that are seeking an attractive yield without adding traditional debt (bonds) that carry strict maturity dates and covenants. Preferred stocks can also be “callable” from the issuer, which has the right to redeem them at a certain price or time at their discretion.

Sometimes the prices of preferred stock indexes follow the path of the stock market and other times they follow a closer inverse relationship to interest rates, like bonds. The result is an alternative income producing asset class with distinctive risk and reward dynamics that must be carefully considered before adding them to your portfolio.

stocks, analysis, market, numbers, business, ticket, trade, money, price


The largest exchange-traded fund in this space is the iShares S&P US Pref Stock Idx Fnd (ETF) (NYSEARCA:PFF). This well-known index-based ETF invests in a basket of nearly 300 preferred stock issues of primarily publicly traded U.S. companies. Think companies like Wells Fargo & Co (NYSE:WFC), HSBC Holdings PLC (ADR) (NYSE:HSBC), and GMAC Capital (ALLY).

The sector makeup of PFF is overwhelmingly dominated by banking, financial, insurance, and real estate stocks. Currently this ETF offers a 30-day SEC yield of 5.28% and charges an expense ratio of 0.47% annually as well.

Examining its recent one-year chart below, it’s notable that iShares S&P US Pref Stock Idx Fnd (ETF) (NYSEARCA:PFF) peaked near the bottom in interest rates in mid-2016 and has been slowly trying to reclaim that prior high. This fund has once again come under fire as signals of more frequent Federal Reserve rate hikes spook interest rates back to the top of their recent range.

The next big test for iShares S&P US Pref Stock Idx Fnd (ETF) (NYSEARCA:PFF) is whether it will be able to hold its long-term 200-day moving average or if it gets sucked down once again by sharply rising Treasury yields. It appears that once again this index is taking its cues from bond holders in terms of its recent price action.

Some investors may be under the impression that PFF is the only ETF in this category because of its dominating $17 billion in total assets that dwarfs the competition. However, there are several options for investors to consider in this category with varying portfolio fees and characteristics.

The PowerShares Preferred Portfolio (ETF) (NYSEARCA:PGX) is the second largest ETF in this class with $4.5 billion in total assets. The underlying PowerShares Preferred Portfolio (ETF) (NYSEARCA:PGX) portfolio and historical returns are markedly similar to PFF, which is why these funds are often interchangeable in terms of security selection.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.